Clinical Trial

A Study of SHR-A1811 in Subjects With Ovarian Cancer

Name: A Study of SHR-A1811 in Subjects With Ovarian Cancer — clinical trial record (NCT06828354)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is an open-label study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with ovarian cancer.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-02-10; most recent amendment 2026-04-15.

Status change: Not Yet Recruiting → Recruiting 2025-03-21

Trial Details

NCT Number	NCT06828354
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Ovarian Cancer
Enrollment	300 participants
Start Date	2025-03-13
Primary Completion	2027-05 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-20